Price $111.21 |
Market Cap
1.46B
|
Sector Health Care |
Div. Growth
14.70%
|
|
P/E
38.4
|
P/B
4.74
|
P/S
2.77
|
Dividend %
1.40%
|
|
P/CF
225.8
|
P/FCF
27.6
|
Op. Cash Flow
70.4K
|
FCF
3.9
|
|
Op. Margin
14.10%
|
Net Margin
7.20%
|
ROE
12.70%
|
ROI
13.90%
|
|
ROA
5.40%
|
EPS Growth
6.80%
|
Current Ratio
1.1
|
Debt/Equity
39.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Endo International PLC (ENDP) | $0.37 | - | - | 124.1M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.07 | - | - | 38.2M | Strong Buy |
| Chembio Diagnostics Inc (CEMI) | $0.65 | - | - | 22.7M | Strong Buy |
| Streamline Health Solutions In (STRM) | $1.25 | - | - | 59.7M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $3.40 | - | - | 14.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
